Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
132.03B
Market cap132.03B
Price-Earnings ratio
27.28
Price-Earnings ratio27.28
Dividend yield
2.80%
Dividend yield2.80%
Average volume
8.98M
Average volume8.98M
High today
$103.02
High today$103.02
Low today
$100.77
Low today$100.77
Open price
$101.74
Open price$101.74
Volume
8.58M
Volume8.58M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.55
52 Week low$79.55

Stock Snapshot

The current Medtronic(MDT) stock price is $102.44, with a market capitalization of 132.03B. The stock trades at a price-to-earnings (P/E) ratio of 27.28 and offers a dividend yield of 2.8%.

As of 2026-01-30, Medtronic(MDT) stock has fluctuated between $100.77 and $103.02. The current price stands at $102.44, placing the stock +1.7% above today's low and -0.6% off the high.

The Medtronic(MDT)'s current trading volume is 8.58M, compared to an average daily volume of 8.98M.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.

MDT News

TipRanks 12h
Medtronic resumed with an Overweight at Wells Fargo

Wells Fargo analyst Larry Biegelsen resumed coverage of Medtronic (MDT) with an Overweight rating and $114 price target The firm says Medtronic remains a top pi...

24/7 Wall St. 14h
Here Are Friday’s Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More

Here Are Friday’s Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More Quick Re...

Simply Wall St 14h
Medtronic Expands Cardiac And Monitoring Ecosystem With New Europe Approvals

Medtronic (NYSE:MDT) has received CE mark approval for its Sphere-360 pulsed field ablation catheter for cardiac arrhythmia treatment. The company has also ext...

Medtronic Expands Cardiac And Monitoring Ecosystem With New Europe Approvals

Analyst ratings

58%

of 31 ratings
Buy
58.1%
Hold
41.9%
Sell
0%

More MDT News

TipRanks 1d
Medtronic initiated with an Outperform at CICC

CICC initiated coverage of Medtronic (MDT) with an Outperform rating and $121 price target Published first on TheFly – the ultimate source for real-time, marke...

Simply Wall St 2d
Is Medtronic Fairly Priced After Recent Steady Share Price Performance

If you are wondering whether Medtronic's current share price reflects fair value or leaves some room on the table, this article will walk through the key facts...

Is Medtronic Fairly Priced After Recent Steady Share Price Performance
Simply Wall St 4d
Should Medtronic’s Pulsed Field Ablation Milestones Reshape Its Cardiac Rhythm Management Strategy?

In recent weeks, Medtronic reported multiple milestones for its Affera Sphere-360 pulsed field ablation catheter, including CE Mark approval in Europe and compl...

Should Medtronic’s Pulsed Field Ablation Milestones Reshape Its Cardiac Rhythm Management Strategy?
Simply Wall St 6d
Medtronic Advances Cardiology And Diabetes Portfolio With New Approvals And Investment

Medtronic (NYSE:MDT) has made a substantial investment in Anteris Technologies to support next generation heart valve development and potential future collabora...

Medtronic Advances Cardiology And Diabetes Portfolio With New Approvals And Investment

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.